The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 26, 2014

Filed:

Aug. 18, 2011
Applicants:

Yoon Jin Lee, Mapo-gu, KR;

Yun-sil Lee, Nowon-gu, KR;

Hae-june Lee, Hwaseong-si, KR;

Seo-hyun Choi, Eunpyeong-gu, KR;

Kyeng-jung Kim, Seoul, KR;

Inventors:

Yoon Jin Lee, Mapo-gu, KR;

Yun-Sil Lee, Nowon-gu, KR;

Hae-June Lee, Hwaseong-si, KR;

Seo-Hyun Choi, Eunpyeong-gu, KR;

Kyeng-Jung Kim, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07K 14/435 (2006.01); C07K 16/44 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 39/395 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for promoting angiogenesis, containing an antibody that specifically binds to heat shock protein (HSP) 27. In addition, the present invention relates to a pharmaceutical composition containing an antibody that specifically binds to HSP 27, for treating an angiogenesis-dependent ailment selected from a group consisting of a wound, chronic ulcer, ischemic stroke, myocardial infarction, angina pectoris, and cerebrovascular dementia. In addition, the present invention relates to a method for promoting the in vitro growth of endothelial cells using an antibody that specifically binds to HSP27. In addition, the present invention relates to a method for screening for active substances for promoting angiogenesis or for active substances for treating an angiogenesis-dependent ailment, the method comprising the following steps: treating vascular endothelial cell lines with each specimen; measuring the content of HSP27 in the respective vascular endothelial cell lines; and selecting a specimen in which the HSP27 content in the vascular endothelial cell lines are decreased as compared to a control group.


Find Patent Forward Citations

Loading…